Graphite Bio Competitors and Similar CompaniesClear all
ProQR Therapeutics's competitors and similar companies include Ambrx.
 ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases. |  Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. | |
Founding Date | Founding Date 2012 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Leiden, NL HQ Cambridge, US | Locations San Diego, US HQ |
Employees | Employees 166 | Employees 70 |
Valuation ($) | Valuation ($) 281.8 m | Valuation ($) 1.8 b |
Financial | ||
Revenue (est.) | Revenue (est.) €15.9m (FY, 2025) | Revenue (est.) $7.4m (FY, 2022) |
Net income | Net income (€42.2m) (FY, 2025) | Net income ($78m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 57.8m | Total funding raised $ 347.9m |
For sources of this data, please see the company profile
View Company Profiles
Ambrx
HQ
San Diego, US
Employees
70
Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
View company